Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (121-130 of 209) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Molecular Cancer Research : MCR|March 17, 2018
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced <i>MIR148A</i> Promoter MethylationTie Li, Christopher D Cox, Byram H Ozer, et al.
Radiology|June 30, 2009
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatmentWhitney B Pope, Hyun J Kim, Jing Huo, et al.
CNS Oncology|July 12, 2019
Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case seriesLiang Yen Liu, Matthew S Ji, Nhung T Nguyen, et al.
Plos One|February 2, 2013
Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metricMaxwell Lewis Neal, Andrew D Trister, Tyler Cloke, et al.
Neuro-Oncology|April 28, 2016
Large-scale assessment of the gliomasphere model systemDan R Laks, Thomas J Crisman, Michelle Y S Shih, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Scientific Reports|February 28, 2019
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistryArarat Chakhoyan, Jingwen Yao, Kevin Leu, et al.
Pageof 21

Showing results (121-130 of 209) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Molecular Cancer Research : MCR|March 17, 2018
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced <i>MIR148A</i> Promoter MethylationTie Li, Christopher D Cox, Byram H Ozer, et al.
Radiology|June 30, 2009
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatmentWhitney B Pope, Hyun J Kim, Jing Huo, et al.
CNS Oncology|July 12, 2019
Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case seriesLiang Yen Liu, Matthew S Ji, Nhung T Nguyen, et al.
Plos One|February 2, 2013
Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metricMaxwell Lewis Neal, Andrew D Trister, Tyler Cloke, et al.
Neuro-Oncology|April 28, 2016
Large-scale assessment of the gliomasphere model systemDan R Laks, Thomas J Crisman, Michelle Y S Shih, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Scientific Reports|February 28, 2019
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistryArarat Chakhoyan, Jingwen Yao, Kevin Leu, et al.
Pageof 21